This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
SMURF1 antibody
catalog :
VPA00234KT
quantity :
2 Westerns
price :
108 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
EntityType :
PrecisionAb™ Polyclonal
EntityCategory :
Antibodies
ProductCode :
VPA00234KT
Description :
SMURF1 ANTIBODY WITH CONTROL LYSATE
Specificity :
SMURF1
TargetSpecies :
Human
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB
ApplicationTypes :
Western Blotting
Quantity :
2 Westerns
QuantityValue :
2
QuantityType :
Westerns
GOAccessions :
GO:0005886, GO:0000209, GO:0042787, GO:0005829, GO:0004842, GO:0006611, GO:0007179, GO:0007398, GO:0030154, GO:0030509, GO:0030512, GO:0030514, GO:0030579, GO:0031398, GO:0032801, GO:0034394, GO:0043161, GO:0048185, GO:0070411, GO:0070412
GOTerms :
activation of protein ubiquitination, anaphase-promoting complex activity, bacterial inner membrane, BMP receptor signaling pathway, BMP signalling pathway, bone morphogenetic protein signaling pathway, bone morphogenetic protein signalling pathway, cell membrane, cytoplasmic membrane, down regulation of BMP signaling pathway, down regulation of transforming growth factor beta receptor signaling pathway, downregulation of BMP signaling pathway, down-regulation of BMP signaling pathway, downregulation of transforming growth factor beta receptor signaling pathway, down-regulation of transforming growth factor beta receptor signaling pathway, E2, E3, GO:0004840, GO:0004841, GO:0005904, GO:0043432, inhibition of BMP signaling pathway, inhibition of transforming growth factor beta receptor signaling pathway, inner endospore membrane, juxtamembrane, myofibrillar protein ubiquitination during ubiquitin-dependent protein breakdown, myofibrillar protein ubiquitination during ubiquitin-dependent protein catabolic process, myofibrillar protein ubiquitination during ubiquitin-dependent protein catabolism, myofibrillar protein ubiquitination during ubiquitin-dependent protein degradation, negative regulation of BMP receptor signaling pathway, negative regulation of BMP signalling pathway, negative regulation of bone morphogenetic protein signaling pathway, negative regulation of bone morphogenetic protein signalling pathway, negative regulation of TGFbeta receptor signaling pathway, negative regulation of TGF-beta receptor signaling pathway, negative regulation of transforming growth factor beta receptor signalling pathway, plasma membrane lipid bilayer, plasmalemma, polyubiquitin, proteasomal pathway, proteasomal processing, proteasomal ubiquitin-dependent protein breakdown, proteasomal ubiquitin-dependent protein catabolism, proteasomal ubiquitin-dependent protein degradation, proteasome pathway, protein degradation tagging activity, protein export from cell nucleus, protein export out of nucleus, protein localisation at cell surface, protein polyubiquitinylation, protein polyubiquitylation, protein transport from nucleus to cytoplasm, protein ubiquitination during ubiquitin-dependent protein breakdown, protein ubiquitination during ubiquitin-dependent protein catabolic process, protein ubiquitination during ubiquitin-dependent protein catabolism, protein ubiquitination during ubiquitin-dependent protein degradation, protein ubiquitinylation during ubiquitin-dependent protein catabolic process, protein ubiquitinylation during ubiquitin-dependent protein catabolism, protein ubiquitylation during ubiquitin-dependent protein catabolic process, protein ubiquitylation during ubiquitin-dependent protein catabolism, protein-nucleus export, receptor breakdown, receptor catabolism, receptor degradation, stimulation of protein ubiquitination, TGFbeta receptor signaling pathway, TGF-beta receptor signaling pathway, TGFbeta receptor signalling pathway, TGF-beta receptor signalling pathway, transforming growth factor beta receptor signalling pathway, ubiquitin activity, ubiquitin conjugating enzyme activity, ubiquitin ligase activity, ubiquitin protein ligase activity, ubiquitin protein-ligase activity, ubiquitin:protein-lysine N-ligase (AMP-forming) activity, ubiquitin-conjugating enzyme activity, ubiquitin-dependent SMAD protein breakdown, ubiquitin-dependent SMAD protein catabolism, ubiquitin-dependent SMAD protein degradation, ubiquitin-ligase activity, up regulation of protein ubiquitination, upregulation of protein ubiquitination, up-regulation of protein ubiquitination
UniprotAccessions :
Q9HCE7
Gene :
SMURF1
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=57154
EntityFormats :
Purified
UNSPSC :
12352203
ProductForm :
Purified IgG - liquid
PriceDKK :
804
PrimarySecondary :
Primary
PriceGBP :
83
PriceEUR :
108
PriceUSD :
108 USD
PriceCHF :
126
PriceSEK :
1077
PriceNOK :
1070
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.